MODY subjects with deleterious hepatocyte nuclear factor 1-alpha (HNF1A) gene mutations are often misdiagnosed as having T2D and importantly, are known to respond more effectively to sulphonylureas than metformin [68,69,70,71,72]. The gene discussed is HNF1A; the disease is type 2 diabetes mellitus.